Aeterna Zentaris announces secondary


Following a big move in the stock over the past few sessions, Aeterna Zentaris (AEZS -0.6%) announces an offering of common stock and warrants.

Shares -8.2% AH.

From other sites
Comments (5)
  • TLR-Controller
    , contributor
    Comment (1) | Send Message
     
    The smart money will buy AEZS, a growing company, as the over reacting not so savvy stockholders sell off. The sale of a new issue adds equity to everyone's shares not unlike earnings. The idea that future earnings per share will be diluted by a new issue and thus lower per share will be immediately offset by the added retained earnings obtained from an infusion of cash provided from the sale of stock. The added funds, cash, bodes well for the future and the continuance of research and growth of the company.
    20 Nov 2013, 12:32 AM Reply Like
  • joust77
    , contributor
    Comments (2) | Send Message
     
    A growing company? Growing in debt and not in marketable bios. They continue to dilute the value of all stockholders. The cash added is by the new shareholders. In actuality, who in their right mind would buy stock in a company that continues to look out for its management's best interest, not the shareholders.
    20 Nov 2013, 07:23 PM Reply Like
  • hkng
    , contributor
    Comments (65) | Send Message
     
    Speculating play. New investors will always step in to play for the hope of successful of the drug.
    20 Nov 2013, 10:26 PM Reply Like
  • RhodeNav
    , contributor
    Comments (253) | Send Message
     
    Just look at their pipeline and there are no more questions. People aggressively buying even trial II not completed companies so why not to get into cheap stock with NDA and phase III drugs??!!
    21 Nov 2013, 04:42 AM Reply Like
  • RhodeNav
    , contributor
    Comments (253) | Send Message
     
    Follow their extra offering distribution - that will explain a lot. Take into account recent NDA and make your conclusions.
    21 Nov 2013, 12:28 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs